Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure

Area of Science:

• Neuroscience
• Pathology
• Environmental Medicine

Background:

• Tauopathies are neurodegenerative diseases characterized by microtubule-associated protein tau (MAPT) dysfunction.
• Disease onset may precede symptoms by two decades, highlighting the need to identify influencing factors.
• Hypoxia is linked to Alzheimer's disease via obstructive sleep apnea and affects tau pathology.

Purpose of the Study:

• To review the influence of hypoxia on tauopathies.
• To explore the contribution of high-altitude exposure to tauopathy development.
• To identify remaining questions regarding hypoxia's role in neurodegeneration.

Main Methods:

• Literature review of studies investigating hypoxia and tauopathy.
• Analysis of molecular pathways affected by hypoxia, including kinase activation and inflammatory responses.
• Examination of evidence linking hypobaric hypoxia to tau hyperphosphorylation and neuroinflammation.

Main Results:

• Hypobaric hypoxia increases tau hyperphosphorylation via kinases (ERK, GSK3β, CDK5).
• Hypoxia elevates inflammatory molecules (IL-β1, IL-6, TNF-α), associated with neurodegeneration.
• Hypoxia impacts molecular pathways relevant to tau dysfunction and aggregation.

Conclusions:

• Hypoxia is a significant factor influencing tauopathy development and progression.
• Further research is needed to elucidate the precise mechanisms linking hypoxia to tauopathies.
• Targeting hypoxia-related factors may offer novel therapeutic strategies for tauopathies.